Volume 2, Issue 9


Combined Therapy of the Erectile Dysfunction in Patients with Arterial Hypertension


Author: Yeugen A. Lytvynets1, Oksana R.Vintoniv 1*

1. SHEE Ivano-Frankivsk National Medical University Ivano-Frankivsk, Ukraine

Abstract: The investigation of the effectiveness of the combined therapy with sildenafil, sildenafil and tivortin, sildenafil, tivortin and LNP therapy was carried out in  120 hypertensive patients with erectile dysfunction. The patients were divided into several groups. Group I (25 patients) got therapy with inhibitors of phosphodiasterase of 5 type (sildenafil) on demand; Group II (25 patients) got sildenafil in a dose of 50mg every other day; Group III (25 patients) – sildenafil in a dose of 50mg every other day + tivortin; Group IV (25 patients) – sildenafil +tivortin+LNP therapy; Group V (20 patients) was a group of comparison. The final estimation of the effectiveness of complex therapy in a month showed good and perfect results in 96,0% of patients of Group IV and 84,0% of patients of Group III. Poorer results were revealed in patients of Group I and Group II. In Group V indexes didn’t change but in 2 patients  (10,0%) results worsened. On the basis of carried out investigation it was established that tivortin and LNP therapy improved treatment.

Download Full Article: Click Here


Support Us

If you are interested in supporting our work and would like to contribute, you are welcome to mail me at jpbr.anil@gmail.com or at info@thepharmajournal.com it will be a great help and will surely be appreciated.